TRIB · Trinity Biotech Plc ADR
United States · RS rating 78 · As of 2026-11-03
| Price | 6.56 USD |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 88 / 14 / 99 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 23 / 32 / 25 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -178.0% |
| Sales growth Q/Q | +4.7% |
| Distance from 52-week high | +51.0% |
| Market cap (USD) | $12.6M |